Critical Care, Ventilation, Etc Flashcards
Inotropy
increased cardiac output
Hypovolemic Shock
<p>**low preload**
low CO
high SVR</p>
<p>Cardiogenic Shock</p>
<p>high preload
**LOW CO**
high SVR</p>
<p>Causes of Cardiogenic Shock</p>
<p>Cardiomyopathy/SHF acute MR or AS Arrthythmia (V fib or complete heart block) Brady or tachy </p>
<p>Distributive Shock</p>
<p>decreased preload
increased CO
decreased SVR</p>
<p>Causes of Distributive Shock</p>
<p>Septic Anaphylaxis Neurogenic Endocrine Drugs</p>
<p>Obstructive Shock</p>
<p>decreased preload
**decreased CO**
increased SVR</p>
<p>Causes of Obstructive Shock</p>
<p>PE or severe RHF
Tension pTx
pericardial tampaonade
restrictive/constriction</p>
<p>Respiratory Acidosis =</p>
<p>increased PCO2
| compensation is increasing bicarb</p>
Respiratory Alkalosis =
decreased PCO2
compensate by decreasing hco3
Metabolic Acidosis =
decreased bicarb
copenensate by decreasing Co2
Metabolic Alkalosis=
increased bicarb
compensate by increasing co23
Delta Gap
AG-12/24-Bicarb;
<1 NGMA;
>1 met alkalosis
Winter’s formula
pco2= 1.5xbicarb + 8 +/-2
Metabolic Alkalosis with hypochloriduria/fluid responsive
vomiting
NG suction
over diuresis
post hypercapnia
<p>ARDS- Berlin Definition</p>
<p>Timing w/in 1 week of symptoms/insult Bilateral opacities Edema (resp failure not fully explained by cardiac failure or volume overload) Poor Oxygenation </p>
<p>Oxygenation Criteria for ARDS - Mild</p>
<p>200-300 PaO2/FiO2 w/ PEEP or CPAP >5</p>
<p>Oxygenation Criteria for ARDS- Moderate</p>
<p>100-200 PaO2/FiO2 w/ PEEP >5</p>
<p>Oxygenation Criteria for ARDS- Severe</p>
<p>Pao2/fio2 <100 w/ peep>5</p>
<p>Stages of ARDS</p>
<p>Exudative
Fibroproliferative
Recovery</p>
<p>Exudative Phase of ARDS</p>
<p>fluid, protein, and inflamm cells leave alveolar capillaries and accumulate in airspace resulting in decreased pulmonary compliance and VQ mismatch (both physiologic shunting and dead space)</p>
<p>Fibroproliferative Phase of ARDS</p>
<p>Chronic inflammation causes connective tissue to proliferates in response to initial injury causing fibrosis. Pulmonary HTN may develop as a result</p>
<p>Recovery Phase of ARDS</p>
<p>Lung reorganizes as the aveloar epithelila barrier is restored. Gradual improvement of lung function over 6-12 months</p>
<p>TV in ARDS</p>
<p>ideal is 6ml/kg </p>
<p>PEEP in ARDS</p>
<p>no difference in outcomes in low vs high PEEP, recommend only using high PEEP in severe ARDS</p>
<p>Steroids in ARDS</p>
<p>no clear evidence
| increased mortality if given after 14+ days (fibroliferative phase)</p>
<p>HFNC in ARDS</p>
<p>decreases intubation </p>
<p>Cisatricurium in ARDS</p>
<p>given in severe ARDS that presented within 48 hours </p>
<p>Agitation in ICU- first line</p>
<p>propofol
| dexmedetomadine</p>
<p>Propofol AE</p>
<p>hyperTG --> pancreatitis
Infusion syndrome w/ lactic acidosis, liver and renal failure, GREEN URINE
</p>
<p>Vascular tone=</p>
<p>resistance</p>
<p>alpha 1&amp;2</p>
<p>blood vessels
| VASOCONSTRICT</p>
<p>beta one</p>
<p>myocardium
| inotropy/chronotropy</p>
<p>Beta two</p>
<p>blood vessels
| vasodilation</p>
<p>V1</p>
<p>blood vessels
| vasoconstriction</p>
<p>NE- what receptors</p>
<p>alpha > beta 1
| Increase SVR w/ slight increase in CO</p>
<p>NE- adverse effects</p>
<p>arrhythmias</p>
<p>Ne- use</p>
<p>first line septic shock</p>
<p>Phenylephirne</p>
<p>alpha one (increase SVR)</p>
<p>Epi</p>
<p>b1 / b2 --> alpha one
| increased SVR w/ higher dose</p>
<p>Phenylephinephrine use</p>
<p>use if arrhythmias w/ NE or as adjunct</p>
<p>Dopamine</p>
<p>D --> B1 --> alpha one</p>
<p>Vasopressin</p>
<p>V1, vasoconstriction
adjunct
high doses decrease UOP</p>
Dobutamine receptors
B1 and B2
increase inotropy, chronotropy
vasodilation and afterload reduce
<p>Dobutamine AE</p>
<p>dysrhythmia, hypotension</p>
Dobutamine indications
<p>cardiogenic shock and HTN
| better w/ RF patients</p>